CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product
RxNorm 2748306
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2748306 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor
(Atom ID: 13066839)
SY
Synonym (SY):
CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product
(Atom ID: 13066840)
PT
Designated preferred name (PT):
Cytotoxic T-lymphocyte-associated protein 4 inhibitor
(Atom ID: 13067036)
PT
Designated preferred name (PT):
Cytotoxic T-lymphocyte-associated protein 4 inhibitor-containing product
(Atom ID: 13067037)
FN
Full form of descriptor (FN):
Product containing cytotoxic T-lymphocyte-associated protein 4 inhibitor (product)
(Atom ID: 13068221)
FN